Germany· DE-A57-4f3ff711e56ab831
Indiace
A medicinal product containing indapamide, ramipril, registered in Germany by Adamed Pharma S.A..
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Indapamide, Ramipril
- Manufacturer
- Adamed Pharma S.A.
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 23, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indapamide, ramipril in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBONTENSEgis Pharmaceuticals PLC, Budapešť
- PolandAmmorroEgis Pharmaceuticals PLC
- SpainIMBARIX 10 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADAAdamed Laboratorios S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Ramindap
- Bulgaria · Полприл Плюс, Рамикомб
- Czechia · Bontens
- Spain · Imbarix
- Hungary · Ammorro, Ramipril/Indapamide Egis Pharmaceuticals Plc
- Italy · Imbaxir, Miprind
- Lithuania · Camimbo
- Latvia · Camimbo
- Poland · Ammorro, Polpril Plus
- Portugal · Imbarix
- Romania · Ramikomb
- Slovakia · Camimbo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/acf3e034-cb31-4950-8d0e-8f7cebee32a3 GET /v1/drugs/acf3e034-cb31-4950-8d0e-8f7cebee32a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Indapamide, Ramipril",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about indapamide, ramipril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.